CD21 primes extrafollicular differentiation of autoreactive B cells in a TLR7-driven lupus model
The extrafollicular (EF) B cell differentiation pathway has emerged as a prominent source of autoantibody-secreting cells (ASCs) in systemic lupus erythematosus (SLE). CD21<sup>lo</sup>CD11c<sup>+</sup> B cells are associated with aging, infection, and autoimmunity. They are key contributors to EF ASCs, yet their developmental trajectory and receptor programming are unclear. To study EF mechanics of autoreactive B cells, we adoptively transferred naïve B cell populations into 564Igi mice, which act as an autoreactive host enriched for autoantigens and T cell help. Time-resolved analyses revealed a Toll-like receptor 7 (TLR7)-dependent early escape of peripheral tolerance and a pre-ASC division program. We identified naïve-derived CD21<sup>lo</sup> cells as precursors of EF ASCs exhibiting elevated reliance on TLR7. Repertoire analysis delineated protoautoreactive B cell selection and receptor evolution toward self-reactivity. Continuous complement receptor 2 (CR2/CD21)-complement C3d and CD21-complement iC3b engagement triggered receptor down-regulation before proliferation. We reveal CD21 as an initiator of TLR7-dependent autoimmune EF proliferation and target for suppressing autoreactivity.
Authors
- Faez Amokrane Nait Mohamed (ORCID: https://orcid.org/0000-0002-5239-4238)
- Minghe Ma (ORCID: https://orcid.org/0000-0002-4496-6240)
- Yi Dan Zhu (ORCID: https://orcid.org/0000-0001-6327-8673)
- Janet E. Buhlmann (ORCID: https://orcid.org/0000-0002-6305-5354)
- Daniel Lingwood (ORCID: https://orcid.org/0000-0001-5631-9238)
- Aaron G. Schmidt (ORCID: https://orcid.org/0000-0003-3627-2553)
- Daniel P. Maurer (ORCID: https://orcid.org/0000-0003-2074-5416)
- Carlos Castrillón (ORCID: https://orcid.org/0000-0003-2909-7371)
- Nathan Higginson-Scott (ORCID: https://orcid.org/0009-0006-7163-3296)
- Jessica Min-DeBartolo (ORCID: https://orcid.org/0000-0002-1554-8365)
- David G. Tang (ORCID: https://orcid.org/0000-0002-6974-5663)
- Michael C. Carroll (ORCID: https://orcid.org/0000-0002-3213-4295)
- Yixiang Deng (ORCID: https://orcid.org/0000-0002-4771-8058)
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Emory University (US)
- Pfizer (United States) (US)
- Ragon Institute of MGH, MIT and Harvard (US)
- Dana-Farber/Harvard Cancer Center (US)
Publication Details
- Journal
- Science Immunology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1126/sciimmunol.ads8226
- Citations
- 1
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.80